Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 5,099 shares at $49.57 ($251K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($251k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.83 | 2,731 | $133K | 53.2% |
| 2 | $49.57 | 2,368 | $117K | 46.8% |
| Total | $49.17 avg | 5,099 | $251K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |